Abstract A083: BRAF Inhibitors in BRAF V600E-Mutated Solid Tumors: A Real World Single Center Experience Post-Tumor-Agnostic FDA Approval
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Sharon Santhosh, Srinivas Govindan, Adit Singhal, Aaron Goldstein, Jervon Wright, Xinhua Zhu
Institution: Northwell Health
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444434
Cites:
Cited by:
Related to: